Canada Cardiac Rhythm Management Devices Market Outlook to 2036 – Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD) and Pacemakers

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4995
Buy Report Download FREE Resources

Published: April 27, 2026 Report Code: GDME5001CCDB-ST

Select Item

GlobalData’s “Canada Cardiac Rhythm Management Devices Outlook to 2036” is a comprehensive databook report, covering key market data on the Canada Cardiac Rhythm Management Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD) and Pacemakers

The Canada Cardiac Rhythm Management Devices Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2024 to 2036.
• 2025 company share data for Cardiac Rhythm Management Devices Market.
• Global corporate-level profiles of key companies operating within the Canada Cardiac Rhythm Management Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

Canada Cardiac Rhythm Management Devices is segmented as follows:

• Cardiac Resynchronisation Therapy (CRT)

• Implantable Cardioverter Defibrillators (ICD)

• Pacemakers

Reasons to Buy

The Canada Cardiac Rhythm Management Devices Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Table of Contents

Table of Contents

List of Tables

List of Figures

1 Introduction

1.1 What Is This Report About?

1.2 Cardiac Rhythm Management Devices Market Segmentation

1.3 Definitions of Markets Covered in the Report

2 Cardiac Rhythm Management Devices Market, Canada

2.1 Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), 2024-2036

2.1.1 Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), by Segment, 2024-2036

2.1.2 Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), by Segment, 2024-2036

2.1.3 Pacemakers Market, Canada, Revenue ($m), by Segment, 2024-2036

2.2 Cardiac Rhythm Management Devices Market, Canada, Volume (Units), 2024-2036

2.2.1 Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), by Segment, 2024-2036

2.2.2 Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), by Segment, 2024-2036

2.2.3 Pacemakers Market, Canada, Volume (Units), by Segment, 2024-2036

2.3 Cardiac Rhythm Management Devices Market, Canada, Average Price ($), 2024-2036

2.4 Cardiac Rhythm Management Devices Market, Canada, Company Share by Revenue ($m), 2025

3 Cardiac Rhythm Management Devices Market Pipeline Products

3.1 Cardiac Rhythm Management Devices Market Pipeline Products

3.2 Cardiac Rhythm Management Devices – Pipeline Products by Stage of Development

3.3 Cardiac Rhythm Management Devices – Pipeline Products by Segment

3.4 Cardiac Rhythm Management Devices – Pipeline Products by Territory

3.5 Cardiac Rhythm Management Devices – Pipeline Products by Regulatory Path

3.6 Cardiac Rhythm Management Devices – Pipeline Products by Estimated Approval Date

4 Overview of Key Companies in Canada, Cardiac Rhythm Management Devices Market

4.1 Medtronic Plc

4.1.1 Company Overview

4.2 Abbott Laboratories

4.2.1 Company Overview

4.3 Biotronik SE & Co KG

4.3.1 Company Overview

4.4 Boston Scientific Corp

4.4.1 Company Overview

4.5 MicroPort Scientific Corp

4.5.1 Company Overview

5 Recent Developments

5.1 Corporate Communications

5.1.1 Nov 03, 2025: Conavi Expands Leadership Team to Support U.S. Commercialization

5.1.2 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund

5.1.3 Oct 29, 2025: Sparrow BioAcoustics Secures $10 Million for U.S. Deployment of Smartphone-Based Cardiac AI

5.1.4 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research

5.1.5 Oct 15, 2025: Anteris Secures European Approval to Launch DurAVR® THV Global Pivotal Trial

5.1.6 Oct 03, 2025: Ventripoint Extends and Upsizes Non-Brokered Convertible Debenture Private Placement

5.2 Government and Public Interest

5.2.1 Sep 30, 2025: Sequana Medical Features Alfapump System at 2025 Portal Intervention Symposium

5.3 Other Significant Developments

5.3.1 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund

5.3.2 Oct 29, 2025: Sparrow BioAcoustics Secures $10 Million for U.S. Deployment of Smartphone-Based Cardiac AI

5.3.3 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research

5.3.4 Oct 06, 2025: Implantica Completes MDSAP Recertification Audit

5.4 Product News

5.4.1 Nov 11, 2025: AI/ML Innovations Announces Grant of U.S. Patent for ECG Signal-Processing Architecture

5.4.2 Nov 04, 2025: Researchers Uncover Genetic Basis of Heart Defects and Facial Differences in Syndrome

5.4.3 Nov 04, 2025: AIML Subsidiary NeuralCloud Solutions Engages Lonacas Consultants for CardioYield Regulatory Submission in Jamaica

5.4.4 Nov 03, 2025: Conavi Expands Leadership Team to Support U.S. Commercialization

5.4.5 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund

5.4.6 Oct 15, 2025: Anteris Secures European Approval to Launch DurAVR® THV Global Pivotal Trial

5.4.7 Oct 06, 2025: Implantica Completes MDSAP Recertification Audit

5.4.8 Oct 06, 2025: QXMédical Announces Settlement With Teleflex, Clearing Path For U.S. Launch Of Boosting Catheter In 2026

5.4.9 Oct 01, 2025: Kardium Begins Commercialization Of Globe System In The USA

5.4.10 Sep 30, 2025: Sequana Medical Features Alfapump System at 2025 Portal Intervention Symposium

5.5 Strategy And Business Planning

5.5.1 Nov 04, 2025: AIML Subsidiary NeuralCloud Solutions Engages Lonacas Consultants for CardioYield Regulatory Submission in Jamaica

5.5.2 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research

5.5.3 Oct 01, 2025: Kardium Begins Commercialization Of Globe System In The USA

5.5.4 Sep 30, 2025: Icentia Reduces Inventory Time by 66% with Odoo

6 Appendix

6.1 Research Methodology

6.1.1 Coverage

6.1.2 Secondary Research

6.1.3 Primary Research

6.1.4 Market Modeling and Forecasting

6.1.5 Company Share Analysis

6.1.6 Benchmarking

6.2 GlobalData Consulting

6.3 Contact Us

6.4 Disclaimer

Table

Table 1: Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036

Table 2: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), USD Constant, 2024-2036

Table 3: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), USD Constant, 2024-2036

Table 4: Pacemakers Market, Canada, Revenue ($m), USD Constant, 2024-2036

Table 5: Cardiac Rhythm Management Devices Market, Canada, Volume (Units), 2024-2036

Table 6: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), 2024-2036

Table 7: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), 2024-2036

Table 8: Pacemakers Market, Canada, Volume (Units), 2024-2036

Table 9: Cardiac Rhythm Management Devices Market, Canada, Average Price ($), 2024-2036

Table 10: Cardiac Rhythm Management Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2025

Table 11: Cardiac Rhythm Management Devices Market Pipeline Products

Table 12: Cardiac Rhythm Management Devices – Pipeline Products by Stage of Development

Table 13: Cardiac Rhythm Management Devices Companies – Pipeline Products by Stage of Development

Table 14: Cardiac Rhythm Management Devices – Pipeline Products by Segment

Table 15: Cardiac Rhythm Management Devices – Pipeline Products by Territory

Table 16: Cardiac Rhythm Management Devices – Pipeline Products by Regulatory Path

Table 17: Cardiac Rhythm Management Devices – Pipeline Products by Estimated Approval Date

Table 18: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country

Figures

Figure 1: Cardiac Rhythm Management Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036

Figure 2: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Revenue ($m), USD Constant, 2024-2036

Figure 3: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Revenue ($m), USD Constant, 2024-2036

Figure 4: Pacemakers Market, Canada, Revenue ($m), USD Constant, 2024-2036

Figure 5: Cardiac Rhythm Management Devices Market, Canada, Volume (Units), 2024-2036

Figure 6: Cardiac Resynchronisation Therapy (CRT) Market, Canada, Volume (Units), 2024-2036

Figure 7: Implantable Cardioverter Defibrillators (ICD) Market, Canada, Volume (Units), 2024-2036

Figure 8: Pacemakers Market, Canada, Volume (Units), 2024-2036

Figure 9: Cardiac Rhythm Management Devices Market, Canada, Company Share (%), 2025

Figure 10: Cardiac Rhythm Management Devices – Pipeline Products by Stage of Development

Figure 11: Cardiac Rhythm Management Devices – Pipeline Products by Segment

Figure 12: Cardiac Rhythm Management Devices – Pipeline Products by Territory

Figure 13: Cardiac Rhythm Management Devices – Pipeline Products by Regulatory Path

Figure 14: Cardiac Rhythm Management Devices – Pipeline Products by Estimated Approval Date

Canada Cardiac Rhythm Management Devices Market Outlook to 2036 – Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD) and Pacemakers standard reports
Currency USD
$4,995

Can be used by individual purchaser only

Most Popular
$9,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$14,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Canada Cardiac Rhythm Management Devices Market Outlook to 2036 – Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD) and Pacemakers was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Cardiovascular Devices reports
Medical Devices
New
Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…
$495 | July 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Medical Devices
New
Traditional Wound Management Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | June 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Canada Cardiac Rhythm Management Devices Market Outlook to 2036 – Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD) and Pacemakers in real time.

  • Access a live Canada Cardiac Rhythm Management Devices Market Outlook to 2036 – Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD) and Pacemakers dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more